Navigation Links
NewYork-Presbyterian/Weill Cornell physician-scientists present at 2010 American Urological Meeting
Date:6/2/2010

NEW YORK (May 29, 2010) -- Physician-scientists from NewYork-Presbyterian Hospital/Weill Cornell Medical Center will present their latest research findings at the American Urological Association's Annual Meeting in San Francisco, May 29 to June 3.

Dr. Steven Kaplan, a urologist and professor of urology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, and Dr. Darracott Vaughan, senior author and professor emeritus of urology at Weill Cornell Medical College, have published data showing that 5-alpha reductase inhibitors (5-ARI), drugs used to control for benign prostatic hypertrophy (BPH), an enlarged prostate, may greatly improve the accuracy of traditional PSA tests for prostate cancer diagnosis.

"Taking 5-ARI drugs may eliminate the background noise associated with PSA testing -- canceling out a benign response and leaving only one signal for malignancy," explains Dr. Kaplan, lead author of the study. "Using PSA testing, we may now be able to distinguish prostate cancer from benign prostatic hyperplasia (BPH) disease."

Dr. Kaplan will present these potentially groundbreaking findings during a press briefing on June 1 at 1:00 p.m. PST and for meeting attendees on June 2 at 12:20 p.m. PST at Moscone North, 120 & 123.

Among the most significant presentations are the following.

  • Surgeons' robotic surgery experience has impact on surgical cancer margins and operative time [2023] Wednesday, June 2, 1:00 p.m. 3:00 p.m.; Moscone North, 130 & 131

    Dr. Ashutosh Tewari
    Director of Robotic Prostatectomy and Prostate Cancer-Urologic Oncology Outcomes and Urologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center; Professor of Urology at Weill Cornell Medical College

    Dr. Tewari will present results from a multi-institutional study examining surgeons' robotic surgical experience. Recent media reports have raised concerns regarding training for robotic surgical procedures. The impact of experience is outlined in this study, demonstrating that greater surgical experience appears to be associated with a reduced percentage of positive surgical cancer margins and operative time after robot-assisted radical prostate removal.

  • Generic form of prostate enlargement drug shows fewer side effects [1786] Tuesday, June 1, 4:30 p.m. 4:40 p.m.; Moscone North, 120 & 123

    Dr. Alexis Te
    Director of the Brady Prostate Center and Urologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center; Professor of Urology at Weill Cornell Medical College

    Dr. Te will present results from a five-year study showing that generic, less-expensive drug for controlling prostate enlargement may produce fewer side-effects, such as erectile dysfunction, ejaculatory dysfunction, lowered libido and breast enlargement. The drugs 5alpha reductase inhibitors (5ARI) have been widely used in the management of men with benign prostatic hypertrophy (BPH). The study compared the generic finasteride and name brand dutasteride.

  • Fewer complications with laparoscopic kidney surgery compared with open [1482] Tuesday, June 1, 11:20 a.m. 11:30 a.m.; Moscone North, 122 & 125

    Dr. Douglas Scherr
    Urologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center; Associate Professor of Urology at Weill Cornell Medical College

    Dr. Scherr will present results showing that laparoscopic surgery has fewer complications than traditional open procedures for the treatment of kidney disease and cancer, such as lowered operative time during laparoscopic partial nephrectomy (LPN), less blood loss and shortened hospital stay.

  • New surgical modification for reduced incontinence following prostate removal [2029] Wednesday, June 2, 1:00 p.m. 3:00 p.m.; Moscone North, 130 & 131

    Dr. Ashutosh Tewari
    Director of Robotic Prostatectomy and Prostate Cancer-Urologic Oncology Outcomes and Urologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center; Professor of Urology at Weill Cornell Medical College

    Dr. Tewari will present findings showing that a surgical modification called the anatomic retro-apical technique reduces incontinence following robotic prostate removal surgery. Incontinence is the most common side effect following prostate removal.


'/>"/>

Contact: Andrew Klein
ank2017@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Columbia University Medical Center
Source:Eurekalert

Related medicine news :

1. National Center on Minority Health and Health Disparities awards $8 million to Weill Cornell
2. iTriage Mobile Healthcare Technology Presented in Washington, DC at the Community Health Data Forum
3. TransforMED's Delta-Exchange Teams with Group Practice Forum to Present Free Webinar Series on Diabetes Population Management
4. RockWest Technology Group Presents Campus Contactless Card Technology at NACCU
5. Choosing Representation Can Help Disability Applicants Avoid Long Lines at Social Security Offices
6. Academic Impacts of Concussions for Students at Issue in House of Representatives
7. NextAid Presents BIDS BUILD HOPE Online Auction to Benefit Projects on the Ground in Africa on World AIDS Orphans Day
8. Harmony Information Systems Selected to Present at Exclusive MAVA Capital Connection 2010 Event
9. Morehead Presents Webinar on “Creating a High-Performing RN Workforce”
10. Meharry Medical College President Testifies Before the U.S. House of Representatives
11. PSA-TEC to Present State of the Industry Panel Discussion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and ... women in the world, and the most handsome men, look naturally attractive. Plastic ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... SYDNEY , June 26, 2016 One of ... , has announced the formation of a new biotechnology company, Noxopharm ... raise $6m in an IPO and to list on the ASX. ... drug candidate, NOX66, ready to enter a Phase 1 clinical study ... been designed to address one of the biggest problems facing cancer ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology: